Skip to content

Contact +44 (0) 20 7060 7474 email us

Pipeline

Research & Development (R&D) Company Pipeline

In this section you can find business information covering life science companies' R&D pipelines. Reports can including disease hub, description, therapeutic indication, mechanism of action, drug class, current trial information, trial details and partnering detail, product revenue, trademarks, corporate partners and management profiles.

Stay up-to-date with new products added to this category »
Title Publication Date Price
Attention Deficit Hyperactivity Disorder (ADHD)
Drug Pipeline Analysis and Market Forecasts to 2015
 December 2009 £1320
Major Depressive Disorder (MDD)
Drug Pipeline Analysis and Market Forecasts to 2015
 December 2009 £1320
Forecast of the Key Pipeline Devices to Impact the Medical Equipment Market by 2012
 December 2008 £2310
Pipeline Insight: Orphan Diseases in Neurology Part III: Myasthenia Gravis
 November 2008 £3965
Pipeline and Commercial Insight: Schizophrenia - Second generation depots protect market value
 October 2008 £5285
Intelligent Medical Devices, Inc. Product Pipeline Analysis
 August 2008 £495
InterGenetics Incorporated Product Pipeline Analysis
 August 2008 £495
Interface Biologics, Inc. Product Pipeline Analysis
 August 2008 £495
Inolase Ltd. Product Pipeline Analysis
 August 2008 £495
Innovent Medical Solutions, Ltd. Product Pipeline Analysis
 August 2008 £495
IRIS International, Inc. Product Pipeline Analysis
 August 2008 £495
Implants International Limited Product Pipeline Analysis
 August 2008 £495
Innocoll Technologies Ltd Product Pipeline Analysis
 August 2008 £495
Interleukin Genetics Incorporated Product Pipeline Analysis
 August 2008 £495
Ivoclar Vivadent AG Product Pipeline Analysis
 August 2008 £495
Kiscomedica Product Pipeline Analysis
 August 2008 £495
Kuros Biosurgery AG Product Pipeline Analysis
 August 2008 £495
Kyphon Inc. Product Pipeline Analysis
 August 2008 £495
Kensey Nash Corporation Product Pipeline Analysis
 August 2008 £495
JenaValve Technology GmbH Product Pipeline Analysis
 August 2008 £495
Jarvik Heart, Inc. Product Pipeline Analysis
 August 2008 £495
Jemo Spine, LLC. Product Pipeline Analysis
 August 2008 £495
IMEXCO General Ltd. Product Pipeline Analysis
 August 2008 £495
Hologic, Inc. Product Pipeline Analysis
 August 2008 £495
FzioMed, Inc. Product Pipeline Analysis
 August 2008 £495
GRANT Life Sciences, Inc. Product Pipeline Analysis
 August 2008 £495
Gen-Probe Incorporated Product Pipeline Analysis
 August 2008 £495
Foster-Miller, Inc. Product Pipeline Analysis
 August 2008 £495
FUJIFILM Medical Systems USA, Inc. Product Pipeline Analysis
 August 2008 £495
Eurocor GmbH Product Pipeline Analysis
 August 2008 £495
ExonHit Therapeutics SA Product Pipeline Analysis
 August 2008 £495
Gene Express, Inc. Product Pipeline Analysis
 August 2008 £495
Genzyme Corporation Product Pipeline Analysis
 August 2008 £495
Endovasc, Inc. Product Pipeline Analysis
 August 2008 £495
LeMaitre Vascular, Inc. Product Pipeline Analysis
 August 2008 £495
HeartWare Limited Product Pipeline Analysis
 August 2008 £495
Epigenomics AG Product Pipeline Analysis
 August 2008 £495
Hai Kang Life Corporation Limited Product Pipeline Analysis
 August 2008 £495
Glycominds Ltd. Product Pipeline Analysis
 August 2008 £495
Greatbatch, Inc. Product Pipeline Analysis
 August 2008 £495
Epinex Diagnostics Incorporated Product Pipeline Analysis
 August 2008 £495
Lifecore Biomedical, Inc. Product Pipeline Analysis
 August 2008 £495
OccuLogix, Inc. Product Pipeline Analysis
 August 2008 £495
Omrix Biopharmaceuticals, Inc. Product Pipeline Analysis
 August 2008 £495
Onconome, Inc. Product Pipeline Analysis
 August 2008 £495
Novo Nordisk AS Product Pipeline Analysis
 August 2008 £495
Northstar Neuroscience, Inc. Product Pipeline Analysis
 August 2008 £495
Nexa Orthopedics, Inc. Product Pipeline Analysis
 August 2008 £495
Nicast LTD Product Pipeline Analysis
 August 2008 £495
Non-Invasive Monitoring Systems, Inc. Product Pipeline Analysis
 August 2008 £495
Optiscan Imaging Limited Product Pipeline Analysis
 August 2008 £495
OraSure Technologies, Inc. Product Pipeline Analysis
 August 2008 £495
OxyBand Technologies, Inc. Product Pipeline Analysis
 August 2008 £495
Paieon Inc. Product Pipeline Analysis
 August 2008 £495
Perceptronix Medical Inc. Product Pipeline Analysis
 August 2008 £495
Osmetech plc Product Pipeline Analysis
 August 2008 £495
Orthovita, Inc. Product Pipeline Analysis
 August 2008 £495
Orion Genomics Product Pipeline Analysis
 August 2008 £495
Ornim, Inc. Product Pipeline Analysis
 August 2008 £495
Ortec International, Inc. Product Pipeline Analysis
 August 2008 £495
Nerites Corporation Product Pipeline Analysis
 August 2008 £495
NMT Medical, Inc. Product Pipeline Analysis
 August 2008 £495
Malaysian Bio-Diagnostics Research Sdn Bhd Product Pipeline Analysis
 August 2008 £495
MedWaves Incorporated Product Pipeline Analysis
 August 2008 £495
Medlogics Device Corporation Product Pipeline Analysis
 August 2008 £495
MND DIAGNOSTIC LTD. Product Pipeline Analysis
 August 2008 £495
MC3, Inc. Product Pipeline Analysis
 August 2008 £495
Edwards Lifesciences Corporation Product Pipeline Analysis
 August 2008 £495
LightLab Imaging, Inc. Product Pipeline Analysis
 August 2008 £495
Lombard Medical Technologies PLC Product Pipeline Analysis
 August 2008 £495
Medtronic, Inc. Product Pipeline Analysis
 August 2008 £495
Merit Medical Systems, Inc. Product Pipeline Analysis
 August 2008 £495
Minos Medical Inc. Product Pipeline Analysis
 August 2008 £495
Miraculins Inc. Product Pipeline Analysis
 August 2008 £495
NIDEK CO., LTD. Product Pipeline Analysis
 August 2008 £495
Mindray Medical International Limited Product Pipeline Analysis
 August 2008 £495
Milagen, Inc. Product Pipeline Analysis
 August 2008 £495
MicroMed Cardiovascular, Inc. Product Pipeline Analysis
 August 2008 £495
Micrus Endovascular Corporation Product Pipeline Analysis
 August 2008 £495
Levitronix LLC Product Pipeline Analysis
 August 2008 £495
ENTrigue Surgical, Inc. Product Pipeline Analysis
 August 2008 £495
Asclepion Laser Technologies GmbH Product Pipeline Analysis
 August 2008 £495
Ash Access Technology, Inc. Product Pipeline Analysis
 August 2008 £495
AtriCure, Inc. Product Pipeline Analysis
 August 2008 £495
Artimplant AB Product Pipeline Analysis
 August 2008 £495
Arthro Kinetics plc Product Pipeline Analysis
 August 2008 £495
Angiotech Pharmaceuticals, Inc. Product Pipeline Analysis
 August 2008 £495
Aptus Endosystems, Inc. Product Pipeline Analysis
 August 2008 £495
Arrow International, Inc. Product Pipeline Analysis
 August 2008 £495
AutoGenomics, Inc. Product Pipeline Analysis
 August 2008 £495
Ayanda Biosystems S.A. Product Pipeline Analysis
 August 2008 £495
Berlin Heart GmbH Product Pipeline Analysis
 August 2008 £495
Bio-Spine Corp. Product Pipeline Analysis
 August 2008 £495
BioCure, Inc. Product Pipeline Analysis
 August 2008 £495
Beckman Coulter, Inc. Product Pipeline Analysis
 August 2008 £495
Bayer HealthCare AG Product Pipeline Analysis
 August 2008 £495
BG Medicine, Inc. Product Pipeline Analysis
 August 2008 £495
BSD Medical Corporation Product Pipeline Analysis
 August 2008 £495
Bausch & Lomb Incorporated Product Pipeline Analysis
 August 2008 £495
Analogic Corporation Product Pipeline Analysis
 August 2008 £495
Amic AB Product Pipeline Analysis
 August 2008 £495
Abbott Diagnostics Product Pipeline Analysis
 August 2008 £495
Access Bio, Inc. Product Pipeline Analysis
 August 2008 £495
AccuTech, LLC Product Pipeline Analysis
 August 2008 £495
AOI Medical, Inc. Product Pipeline Analysis
 August 2008 £495
AI Medical Devices Inc. Product Pipeline Analysis
 August 2008 £495
8sens.biognostic GmbH Product Pipeline Analysis
 August 2008 £495
A&G Pharmaceutical, Inc. Product Pipeline Analysis
 August 2008 £495
A-Spine Holding Group Corp. Product Pipeline Analysis
 August 2008 £495
Active Implants Corporation Product Pipeline Analysis
 August 2008 £495
AdnaGen AG Product Pipeline Analysis
 August 2008 £495
Alfa Scientific Designs, Inc. Product Pipeline Analysis
 August 2008 £495
Align Technology, Inc. Product Pipeline Analysis
 August 2008 £495
Alphatec Holdings, Inc. Product Pipeline Analysis
 August 2008 £495
Alcon, Inc. Product Pipeline Analysis
 August 2008 £495
Advanced Surgical Design & Manufacture Limited Product Pipeline Analysis
 August 2008 £495
Advanced Medical Optics, Inc. Product Pipeline Analysis
 August 2008 £495
Advanced Refractive Technologies, Inc. Product Pipeline Analysis
 August 2008 £495
BioTex, Inc. Product Pipeline Analysis
 August 2008 £495
Bioheart, Inc. Product Pipeline Analysis
 August 2008 £495
Corgenix, Inc. Product Pipeline Analysis
 August 2008 £495
Corin Group PLC Product Pipeline Analysis
 August 2008 £495
Correlogic Systems, Inc. Product Pipeline Analysis
 August 2008 £495
Cordis Corporation Product Pipeline Analysis
 August 2008 £495
CorNova, Inc. Product Pipeline Analysis
 August 2008 £495
Confluent Surgical Inc. Product Pipeline Analysis
 August 2008 £495
Cook Medical Product Pipeline Analysis
 August 2008 £495
CorAssist Cardiovascular Ltd. Product Pipeline Analysis
 August 2008 £495
CryoLife, Inc. Product Pipeline Analysis
 August 2008 £495
Cyberkinetics Neurotechnology Systems, Inc. Product Pipeline Analysis
 August 2008 £495
Disc Motion Technologies Product Pipeline Analysis
 August 2008 £495
Doxa AB Product Pipeline Analysis
 August 2008 £495
Philips Medical Systems Product Pipeline Analysis
 August 2008 £495
DiaGenic ASA Product Pipeline Analysis
 August 2008 £495
Debiotech S.A. Product Pipeline Analysis
 August 2008 £495
CytoCore, Inc. Product Pipeline Analysis
 August 2008 £495
DNAPrint Genomics, Inc. Product Pipeline Analysis
 August 2008 £495
DePuy, Inc. Product Pipeline Analysis
 August 2008 £495
CompuMed, Inc. Product Pipeline Analysis
 August 2008 £495
Collagen Matrix, Inc. Product Pipeline Analysis
 August 2008 £495
Boston Scientific Corporation Product Pipeline Analysis
 August 2008 £495
C.R. Bard, Inc. Product Pipeline Analysis
 August 2008 £495
Cardima, Inc. Product Pipeline Analysis
 August 2008 £495
Biotest Diagnostics Corporation Product Pipeline Analysis
 August 2008 £495
Biosite Incorporated Product Pipeline Analysis
 August 2008 £495
Biomet, Inc. Product Pipeline Analysis
 August 2008 £495
Bioring SA Product Pipeline Analysis
 August 2008 £495
Bioscan Technologies Inc. Product Pipeline Analysis
 August 2008 £495
Cardiogenesis Corporation Product Pipeline Analysis
 August 2008 £495
Carestream Health, Inc. Kodak Health Group Product Pipeline Analysis
 August 2008 £495
China Medical Technologies, Inc. Product Pipeline Analysis
 August 2008 £495
China Sky One Medical, Inc. Product Pipeline Analysis
 August 2008 £495
Clinical Cell Culture Limited Product Pipeline Analysis
 August 2008 £495
Chembio Diagnostic Systems, Inc. Product Pipeline Analysis
 August 2008 £495
CellTran Limited Product Pipeline Analysis
 August 2008 £495
Carl Zeiss Meditec AG Product Pipeline Analysis
 August 2008 £495
CathRx Ltd Product Pipeline Analysis
 August 2008 £495
Eden Spine, LLC Product Pipeline Analysis
 August 2008 £495
Hansen Medical, Inc. Product Pipeline Analysis
 August 2008 £495
Translumina GmbH Product Pipeline Analysis
 August 2008 £495
pSivida Limited Product Pipeline Analysis
 August 2008 £495
ev3 Inc. Product Pipeline Analysis
 August 2008 £495
diaDexus, Inc. Product Pipeline Analysis
 August 2008 £495
AGA Medical Corporation Product Pipeline Analysis
 August 2008 £495
BIOTRONIK GmbH & Co. KG Product Pipeline Analysis
 August 2008 £495
BodyTel Scientific Inc. Product Pipeline Analysis
 August 2008 £495
Biocompatibles International plc Product Pipeline Analysis
 August 2008 £495
BioTech One Inc Product Pipeline Analysis
 August 2008 £495
aap Implantate AG Product Pipeline Analysis
 August 2008 £495
Zimmer Holdings, Inc. Product Pipeline Analysis
 August 2008 £495
VentriPoint, Inc. Product Pipeline Analysis
 August 2008 £495
Ventana Medical Systems, Inc. Product Pipeline Analysis
 August 2008 £495
VERTEBRON Inc. Product Pipeline Analysis
 August 2008 £495
U.S. Spinal Technologies, LLC Product Pipeline Analysis
 August 2008 £495
Veryan Medical Product Pipeline Analysis
 August 2008 £495
Visual Pathways, Inc. Product Pipeline Analysis
 August 2008 £495
ZONARE Medical Systems, Inc. Product Pipeline Analysis
 August 2008 £495
Xhale Diagnostics, Inc. Product Pipeline Analysis
 August 2008 £495
XTENT, Inc. Product Pipeline Analysis
 August 2008 £495
CSMG Technologies, Inc. Product Pipeline Analysis
 August 2008 £495
Cepheid Product Pipeline Analysis
 August 2008 £495
KYOCERA Corporation Product Pipeline Analysis
 August 2008 £495
LDR Holding Corporation Product Pipeline Analysis
 August 2008 £495
LifeAssays AB Product Pipeline Analysis
 August 2008 £495
MAKO Surgical Corp. Product Pipeline Analysis
 August 2008 £495
Insight MRI Product Pipeline Analysis
 August 2008 £495
Innova Biotechnology Co., Ltd. Product Pipeline Analysis
 August 2008 £495
Protein Polymer Technologies, Inc. Product Pipeline Analysis
 August 2008 £495
Globus Medical, Inc. Product Pipeline Analysis
 August 2008 £495
Inion Oy Product Pipeline Analysis
 August 2008 £495
Pioneer Surgical Technology, Inc. Product Pipeline Analysis
 August 2008 £495
Reliant Technologies Inc. Product Pipeline Analysis
 August 2008 £495
ECI Biotech Inc. Product Pipeline Analysis
 August 2008 £495
Diazyme Laboratories Product Pipeline Analysis
 August 2008 £495
CooperVision, Inc. Product Pipeline Analysis
 August 2008 £495
GUIDED THERAPEUTICS, INC. Product Pipeline Analysis
 August 2008 £495
Gambro AB Product Pipeline Analysis
 August 2008 £495
Scient'x USA Product Pipeline Analysis
 August 2008 £265
Siemens AG Product Pipeline Analysis
 August 2008 £495
Sorin S.p.A. Product Pipeline Analysis
 August 2008 £495
Toshiba America Medical Systems, Inc. Product Pipeline Analysis
 August 2008 £495
eXagen DIAGNOSTICS, Inc. Product Pipeline Analysis
 August 2008 £495
Shina Systems Ltd. Product Pipeline Analysis
 August 2008 £495
Serica Technologies, Inc. Product Pipeline Analysis
 August 2008 £495
Sequella, Inc. Product Pipeline Analysis
 August 2008 £495
SensiGen, LLC. Product Pipeline Analysis
 August 2008 £495
Siemens Medical Solutions Product Pipeline Analysis
 August 2008 £495
Sientra, Inc. Product Pipeline Analysis
 August 2008 £495
Spine Smith, LP Product Pipeline Analysis
 August 2008 £495
Smith & Nephew Plc Product Pipeline Analysis
 August 2008 £495
Small Bone Innovations, Inc. Product Pipeline Analysis
 August 2008 £495
Sahajanand Medical technologies Pvt. Ltd. Product Pipeline Analysis
 August 2008 £495
Tissue Repair Company Product Pipeline Analysis
 August 2008 £495
Ranier Technology Limited Product Pipeline Analysis
 August 2008 £495
Rafael Medical Technologies, Inc. Product Pipeline Analysis
 August 2008 £495
Qiagen N.V. Product Pipeline Analysis
 August 2008 £495
QUASAR, Inc. Product Pipeline Analysis
 August 2008 £495
Raymedica, LLC Product Pipeline Analysis
 August 2008 £495
Regentis Biomaterials Ltd. Product Pipeline Analysis
 August 2008 £495
SQI Diagnostics Inc. Product Pipeline Analysis
 August 2008 £495
SEQUENOM, Inc. Product Pipeline Analysis
 August 2008 £495
Roche Diagnostics Limited Product Pipeline Analysis
 August 2008 £495
SpineCraft, Inc. Product Pipeline Analysis
 August 2008 £495
STAAR Surgical Company Product Pipeline Analysis
 August 2008 £495
The Magstim Company Limited Product Pipeline Analysis
 August 2008 £495
Terumo Corporation Product Pipeline Analysis
 August 2008 £495
Tepha, Inc. Product Pipeline Analysis
 August 2008 £495
Targeted Diagnostics & Therapeutics, Inc. Product Pipeline Analysis
 August 2008 £495
Theken Spine, LLC Product Pipeline Analysis
 August 2008 £495
ThermoGenesis Corp. Product Pipeline Analysis
 August 2008 £495
Spire Corporation Product Pipeline Analysis
 August 2008 £495
Thoratec Corporation Product Pipeline Analysis
 August 2008 £495
Third Wave Technologies, Inc. Product Pipeline Analysis
 August 2008 £495
Target Discovery, Inc. Product Pipeline Analysis
 August 2008 £495
The Spectranetics Corporation Product Pipeline Analysis
 August 2008 £495
Stryker Corporation Product Pipeline Analysis
 August 2008 £495
Straumann Holding AG Product Pipeline Analysis
 August 2008 £495
TEKIA, INC. Product Pipeline Analysis
 August 2008 £495
St. Jude Medical Inc. Product Pipeline Analysis
 August 2008 £495
Symphony Medical, Inc. Product Pipeline Analysis
 August 2008 £495
SutureAid Product Pipeline Analysis
 August 2008 £495
Synovis Life Technologies, Inc. Product Pipeline Analysis
 August 2008 £495
SyntheMed, Inc. Product Pipeline Analysis
 August 2008 £495
Pipeline Insight: Non-insulin antidiabetics Incretin mimetics leaders in a diverse pipeline
 May 2008 £3965
Kidneys and Genito-Urinary System - Benign Prostatic Hyperplasia Drug Pipeline Report
 February 2008 £655
Kidneys and Genito-Urinary System - Diabetic Nephropathy Drug Pipeline Report
 February 2008 £655
Kidney Cancer Drug Pipeline Report
 February 2008 £985
Infections - Urinary Tract Infections Drug Pipeline Report
 February 2008 £655
Kidneys and Genito-Urinary System - Erectile Dysfunction Drug Pipeline Report
 February 2008 £655
Infections - Viral Infections Drug Pipeline Report
 February 2008 £655
Liver Cancer Drug Pipeline Report
 February 2008 £655
Infections - Tuberculosis Drug Pipeline Report
 February 2008 £655
Melanoma or Skin Cancer Drug Pipeline Report
 February 2008 £985
Kidneys and Genito-Urinary System - Urinary Incontinence Drug Pipeline Report
 February 2008 £655
Kidneys and Genito-Urinary System - Overactive Bladder Drug Pipeline Report
 February 2008 £655
Kidneys and Genito-Urinary System - Kidney Stones Drug Pipeline Report
 February 2008 £655
Kidneys and Genito-Urinary System - Hyperphosphatemia Drug Pipeline Report
 February 2008 £655
Infections - Ear Infections Drug Pipeline Report
 February 2008 £655
Infections - Fungal Infections or Candidiasis Drug Pipeline Report
 February 2008 £985
Infections - Helminthic Infestations Drug Pipeline Report
 February 2008 £655
Infections - Fever Drug Pipeline Report
 February 2008 £655
Infections - Bacterial Infections Drug Pipeline Report
 February 2008 £985
Metabolic Endocrinology - Cachexia Drug Pipeline Report
 February 2008 £655
Infections - Hepatitis B Drug Pipeline Report
 February 2008 £985
Infections - Hepatitis C Drug Pipeline Report
 February 2008 £985
Infections - Pneumonia Drug Pipeline Report
 February 2008 £985
Infections - Malaria Drug Pipeline Report
 February 2008 £655
Infections - Influenza Drug Pipeline Report
 February 2008 £985
Infections - Herpes Simplex Virus Infection Drug Pipeline Report
 February 2008 £655
Infections - Staphylococcal Infections Drug Pipeline Report
 February 2008 £985
Infections - AIDS HIV Drug Pipeline Report
 February 2008 £985
Respiratory and Pulmonary System - Chronic Obstructive Pulmonary Disease Drug Pipeline Report
 February 2008 £985
Respiratory and Pulmonary System - Cough Drug Pipeline Report
 February 2008 £655
Respiratory and Pulmonary System - Cystic Fibrosis Drug Pipeline Report
 February 2008 £655
Respiratory and Pulmonary System - Nasal congestion Drug Pipeline Report
 February 2008 £655
Respiratory and Pulmonary System - Bronchospasm Drug Pipeline Report
 February 2008 £655
Respiratory and Pulmonary System - Bronchitis Drug Pipeline Report
 February 2008 £655
Pancreatic Cancer Drug Pipeline Report
 February 2008 £985
Prostate Cancer Drug Pipeline Report
 February 2008 £985
Respiratory and Pulmonary System - Asthma Drug Pipeline Report
 February 2008 £985
Substance Abuse - Alcoholism Drug Pipeline Report
 February 2008 £655
Substance Abuse - Antidote Drug Pipeline Report
 February 2008 £655
Women's Health - Menopausal Symptoms Drug Pipeline Report
 February 2008 £655
Women's Health - Vaginal Infections Drug Pipeline Report
 February 2008 £655
Metabolic Endocrinology - Diabetic Neuropathy Drug Pipeline Report
 February 2008 £655
Women's Health - Infertility Drug Pipeline Report
 February 2008 £655
Women's Health - Female Sexual Dysfunction Drug Pipeline Report
 February 2008 £655
Substance Abuse - Poisoning Drug Pipeline Report
 February 2008 £655
Substance Abuse - Smoking Cessation Drug Pipeline Report
 February 2008 £655
Women's Health - Contraception Drug Pipeline Report
 February 2008 £655
Ovarian Cancer Drug Pipeline Report
 February 2008 £985
Women's Health - Endometriosis Drug Pipeline Report
 February 2008 £655
Metabolic Endocrinology - Type II Diabetes Drug Pipeline Report
 February 2008 £985
Metabolic Endocrinology - Vitamin Deficiency Drug Pipeline Report
 February 2008 £655
Multiple Myeloma Drug Pipeline Report
 February 2008 £985
Metabolic Endocrinology - Type I Diabetes Drug Pipeline Report
 February 2008 £655
Metabolic Endocrinology - Hypogonadism Drug Pipeline Report
 February 2008 £655
Metabolic Endocrinology - Hypercalcemia Drug Pipeline Report
 February 2008 £655
Ophthalmology and Optometry - Ocular Inflammation Drug Pipeline Report
 February 2008 £655
Metabolic Endocrinology - Hypocalcemia Drug Pipeline Report
 February 2008 £655
Musculo-Skeletal-Disorders - Gout Drug Pipeline Report
 February 2008 £655
Metabolic Endocrinology - Obesity Drug Pipeline Report
 February 2008 £985
Ophthalmology and Optometry - Eye Infections Drug Pipeline Report
 February 2008 £655
Musculo-Skeletal-Disorders - Muscle Pain Drug Pipeline Report
 February 2008 £655
Ophthalmology and Optometry - Macular Degeneration Drug Pipeline Report
 February 2008 £985
Ophthalmology and Optometry - Glaucoma Drug Pipeline Report
 February 2008 £985
Ophthalmology and Optometry - Conjunctivitis Drug Pipeline Report
 February 2008 £655
Ophthalmology and Optometry - Dry Eyes Drug Pipeline Report
 February 2008 £655
Non-Hodgkin Lymphoma Drug Pipeline Report
 February 2008 £985
Non-Small-Cell Lung Cancer or Lung Cancer or Small Cell Lung Cancer Drug Pipeline Report
 February 2008 £985
Musculo-Skeletal-Disorders - Osteoarthritis Drug Pipeline Report
 February 2008 £985
Shire plc -Detailed Product Pipeline
 February 2008 £250
Simcere Pharmaceutical Group. -Detailed Product Pipeline
 February 2008 £250
Sinobiomed Inc. -Detailed Product Pipeline
 February 2008 £250
Sepracor Inc -Detailed Product Pipeline
 February 2008 £250
Sirtris Pharmaceuticals, Inc. -Detailed Product Pipeline
 February 2008 £250
Sinofresh Healthcare Inc -Detailed Product Pipeline
 February 2008 £250
Sinovac Biotech Ltd -Detailed Product Pipeline
 February 2008 £250
SciClone Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
SkyePharma Plc -Detailed Product Pipeline
 February 2008 £250
Savient Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Schering -Plough Corp -Detailed Product Pipeline
 February 2008 £250
Schwarz Pharma Ag -Detailed Product Pipeline
 February 2008 £250
Seattle Genetics Inc -Detailed Product Pipeline
 February 2008 £250
Sciele Pharma, Inc. -Detailed Product Pipeline
 February 2008 £250
Senetek Plc -Detailed Product Pipeline
 February 2008 £250
StemCells Inc -Detailed Product Pipeline
 February 2008 £250
Sucampo Pharmaceuticals, Inc. -Detailed Product Pipeline
 February 2008 £250
Stryker Corp -Detailed Product Pipeline
 February 2008 £250
Sunesis Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
SuperGen Inc -Detailed Product Pipeline
 February 2008 £250
Santarus Inc -Detailed Product Pipeline
 February 2008 £250
Swiss Medica Inc -Detailed Product Pipeline
 February 2008 £250
Stem Cell Innovations Inc -Detailed Product Pipeline
 February 2008 £250
Stellar Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Somaxon Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Solbec Pharmaceuticals Ltd -Detailed Product Pipeline
 February 2008 £250
Sonus Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Spectrum Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Starpharma Holdings Ltd -Detailed Product Pipeline
 February 2008 £250
Spherix Incorporated -Detailed Product Pipeline
 February 2008 £250
Smith & Nephew Plc -Detailed Product Pipeline
 February 2008 £250
Questcor Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Psivida Ltd -Detailed Product Pipeline
 February 2008 £250
Provectus Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
QLT Inc -Detailed Product Pipeline
 February 2008 £250
Sygnis Pharma AG -Detailed Product Pipeline
 February 2008 £250
Regen Therapeutics plc -Detailed Product Pipeline
 February 2008 £250
Raptor Pharmaceuticals Corp. -Detailed Product Pipeline
 February 2008 £250
Protherics PLC -Detailed Product Pipeline
 February 2008 £250
Proteo Inc -Detailed Product Pipeline
 February 2008 £250
Procyon Corp. -Detailed Product Pipeline
 February 2008 £250
Procter & Gamble Company -Detailed Product Pipeline
 February 2008 £250
Progen Pharmaceuticals Ltd. -Detailed Product Pipeline
 February 2008 £250
Progenics Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Protalix BioTherapeutics, Inc. -Detailed Product Pipeline
 February 2008 £250
Protalex Inc -Detailed Product Pipeline
 February 2008 £250
RegeneRx Biopharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Regeneron Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
SIGA Technologies Inc -Detailed Product Pipeline
 February 2008 £250
SGX Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Salix Pharmaceuticals Ltd -Detailed Product Pipeline
 February 2008 £250
Samaritan Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Sanguine Corp -Detailed Product Pipeline
 February 2008 £250
Sangamo BioSciences Inc -Detailed Product Pipeline
 February 2008 £250
SCOLR Pharma Inc -Detailed Product Pipeline
 February 2008 £250
Roche Holdings Ltd -Detailed Product Pipeline
 February 2008 £250
Replidyne Inc -Detailed Product Pipeline
 February 2008 £250
Renovis Inc -Detailed Product Pipeline
 February 2008 £250
Repligen Corporation -Detailed Product Pipeline
 February 2008 £250
Repros Therapeutics Inc -Detailed Product Pipeline
 February 2008 £250
Rigel Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Rexahn Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Sanofi -Aventis -Detailed Product Pipeline
 February 2008 £250
Titan Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Viragen Inc -Detailed Product Pipeline
 February 2008 £250
Vion Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Viral Genetics Inc -Detailed Product Pipeline
 February 2008 £250
Viropharma Inc -Detailed Product Pipeline
 February 2008 £250
Vyrex Corp -Detailed Product Pipeline
 February 2008 £250
Vital Living Inc -Detailed Product Pipeline
 February 2008 £250
VioQuest Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Vical Inc -Detailed Product Pipeline
 February 2008 £250
Vaso Active Pharmaceuticals -Detailed Product Pipeline
 February 2008 £250
Vanda Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Vasogen Inc -Detailed Product Pipeline
 February 2008 £250
Vernalis Plc ADR -Detailed Product Pipeline
 February 2008 £250
ViRexx Medical Corp -Detailed Product Pipeline
 February 2008 £250
Vertex Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Vyteris Holdings (Nevada) Inc -Detailed Product Pipeline
 February 2008 £250
Warner Chilcott Limited -Detailed Product Pipeline
 February 2008 £250
ZIOPHARM Oncology Inc -Detailed Product Pipeline
 February 2008 £250
YM BioSciences Inc -Detailed Product Pipeline
 February 2008 £250
Zila Inc -Detailed Product Pipeline
 February 2008 £250
ZymoGenetics Inc -Detailed Product Pipeline
 February 2008 £250
Pro -Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
deCODE genetics Inc -Detailed Product Pipeline
 February 2008 £250
Xenoport Inc -Detailed Product Pipeline
 February 2008 £250
Xechem International Inc. -Detailed Product Pipeline
 February 2008 £250
Women First Healthcare Inc. -Detailed Product Pipeline
 February 2008 £250
Watson Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Wyeth -Detailed Product Pipeline
 February 2008 £250
XELR8, Inc. -Detailed Product Pipeline
 February 2008 £250
XTL Biopharmaceuticals Ltd -Detailed Product Pipeline
 February 2008 £250
XOMA Ltd -Detailed Product Pipeline
 February 2008 £250
Valeant Pharmaceuticals International -Detailed Product Pipeline
 February 2008 £250
VIVUS Inc -Detailed Product Pipeline
 February 2008 £250
Targeted Genetics Corp -Detailed Product Pipeline
 February 2008 £250
Targanta Therapeutics Corp. -Detailed Product Pipeline
 February 2008 £250
Taro Pharmaceutical Industries Ltd -Detailed Product Pipeline
 February 2008 £250
Telik Inc -Detailed Product Pipeline
 February 2008 £250
Tetragenex Pharmaceuticals, Inc. -Detailed Product Pipeline
 February 2008 £250
Tercica Inc -Detailed Product Pipeline
 February 2008 £250
Targacept Inc -Detailed Product Pipeline
 February 2008 £250
Tapestry Pharmaceuticals, Inc. -Detailed Product Pipeline
 February 2008 £250
Synta Pharmaceuticals Corp. -Detailed Product Pipeline
 February 2008 £250
Synovics Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
SyntheMed Inc -Detailed Product Pipeline
 February 2008 £250
Synthetic Blood International Inc -Detailed Product Pipeline
 February 2008 £250
TapImmune, Inc. -Detailed Product Pipeline
 February 2008 £250
Synvista Therapeutics, Inc. -Detailed Product Pipeline
 February 2008 £250
Teva Pharmaceutical Industries Ltd -Detailed Product Pipeline
 February 2008 £250
The Medicines Company -Detailed Product Pipeline
 February 2008 £250
USANA Health Sciences Inc -Detailed Product Pipeline
 February 2008 £250
ULURU Inc -Detailed Product Pipeline
 February 2008 £250
Unigene Laboratories Inc -Detailed Product Pipeline
 February 2008 £250
United Therapeutics Corporation -Detailed Product Pipeline
 February 2008 £250
VIA Pharmaceuticals, Inc. -Detailed Product Pipeline
 February 2008 £250
Urigen Pharmaceuticals, Inc. -Detailed Product Pipeline
 February 2008 £250
Trubion Pharmaceuticals Inc. -Detailed Product Pipeline
 February 2008 £250
Trimeris Inc -Detailed Product Pipeline
 February 2008 £250
Theravance Inc -Detailed Product Pipeline
 February 2008 £250
The Quigley Corporation -Detailed Product Pipeline
 February 2008 £250
Threshold Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
TorreyPines Therapeutics, Inc. -Detailed Product Pipeline
 February 2008 £250
Transition Therapeutics Inc. -Detailed Product Pipeline
 February 2008 £250
Symbollon Pharmaceuticals Inc CL A -Detailed Product Pipeline
 February 2008 £250
Orexigen Therapeutics, Inc. -Detailed Product Pipeline
 February 2008 £250
Dragon Pharmaceutical Inc -Detailed Product Pipeline
 February 2008 £250
Duska Therapeutics Inc -Detailed Product Pipeline
 February 2008 £250
Dyax Corp -Detailed Product Pipeline
 February 2008 £250
Dynavax Technologies Corp -Detailed Product Pipeline
 February 2008 £250
Dr Reddys Laboratories Ltd -Detailed Product Pipeline
 February 2008 £250
Dov Pharmaceutical Inc -Detailed Product Pipeline
 February 2008 £250
Derma Sciences Inc -Detailed Product Pipeline
 February 2008 £250
Diamyd Medical AB -Detailed Product Pipeline
 February 2008 £250
Discovery Laboratories Inc -Detailed Product Pipeline
 February 2008 £250
Dnaprint Genomics Inc -Detailed Product Pipeline
 February 2008 £250
EPIX Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Echo Therapeutics, Inc -Detailed Product Pipeline
 February 2008 £250
Emisphere Technologies Inc -Detailed Product Pipeline
 February 2008 £250
Encysive Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Endo Pharmaceuticals Holdings Inc -Detailed Product Pipeline
 February 2008 £250
Endovasc Inc (NV) -Detailed Product Pipeline
 February 2008 £250
Emergent BioSolutions Inc -Detailed Product Pipeline
 February 2008 £250
Elite Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Eisai Co Ltd -Detailed Product Pipeline
 February 2008 £250
Elan Corp Plc -Detailed Product Pipeline
 February 2008 £250
Eli Lilly & Co -Detailed Product Pipeline
 February 2008 £250
Depomed Inc -Detailed Product Pipeline
 February 2008 £250
Dendreon Corp -Detailed Product Pipeline
 February 2008 £250
Curis Inc -Detailed Product Pipeline
 February 2008 £250
Cyanotech Corporation -Detailed Product Pipeline
 February 2008 £250
Cyclacel Pharmaceuticals, Inc. -Detailed Product Pipeline
 February 2008 £250
Cyplasin Biomedical Ltd. -Detailed Product Pipeline
 February 2008 £250
CuraGen Corp -Detailed Product Pipeline
 February 2008 £250
Cubist Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Cougar Biotechnology, Inc. -Detailed Product Pipeline
 February 2008 £250
Critical Therapeutics Inc -Detailed Product Pipeline
 February 2008 £250
Crucell N V -Detailed Product Pipeline
 February 2008 £250
Cypress Bioscience Incorporated -Detailed Product Pipeline
 February 2008 £250
CytRx Corporation -Detailed Product Pipeline
 February 2008 £250
DOR BioPharma Inc -Detailed Product Pipeline
 February 2008 £250
DRAXIS Health Inc -Detailed Product Pipeline
 February 2008 £250
DURECT Corporation -Detailed Product Pipeline
 February 2008 £250
DUSA Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
DENTSPLY International Inc -Detailed Product Pipeline
 February 2008 £250
Cytos Biotechnology AG -Detailed Product Pipeline
 February 2008 £250
CytoDyn Inc -Detailed Product Pipeline
 February 2008 £250
Cytogenix Inc -Detailed Product Pipeline
 February 2008 £250
Cytokinetics Inc -Detailed Product Pipeline
 February 2008 £250
Enhance Biotech Inc -Detailed Product Pipeline
 February 2008 £250
EntreMed Inc -Detailed Product Pipeline
 February 2008 £250
Gentium S.p.A -Detailed Product Pipeline
 February 2008 £250
Genzyme Corporation -Detailed Product Pipeline
 February 2008 £250
GeoPharma Inc -Detailed Product Pipeline
 February 2008 £250
GeoVax Labs Inc -Detailed Product Pipeline
 February 2008 £250
Genta Incorporated -Detailed Product Pipeline
 February 2008 £250
Genitope Corp -Detailed Product Pipeline
 February 2008 £250
Genelabs Technologies Inc -Detailed Product Pipeline
 February 2008 £250
Genentech Inc -Detailed Product Pipeline
 February 2008 £250
Generex Biotechnology Corporation -Detailed Product Pipeline
 February 2008 £250
Geron Corporation -Detailed Product Pipeline
 February 2008 £250
Gilead Sciences Inc -Detailed Product Pipeline
 February 2008 £250
Hemispherx Biopharma Inc -Detailed Product Pipeline
 February 2008 £250
Hemobiotech Inc -Detailed Product Pipeline
 February 2008 £250
Hi -Tech Pharmacal Co Inc -Detailed Product Pipeline
 February 2008 £250
Hollis -Eden Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Helix BioMedix Inc -Detailed Product Pipeline
 February 2008 £250
Hana Biosciences Inc -Detailed Product Pipeline
 February 2008 £250
GlaxoSmithKline plc -Detailed Product Pipeline
 February 2008 £250
H.Lundbeck AS -Detailed Product Pipeline
 February 2008 £250
Prescient NeuroPharma Inc -Detailed Product Pipeline
 February 2008 £250
Genaera Corporation -Detailed Product Pipeline
 February 2008 £250
GenVec Inc -Detailed Product Pipeline
 February 2008 £250
Eugene Science Inc -Detailed Product Pipeline
 February 2008 £250
Eurand N.V. -Detailed Product Pipeline
 February 2008 £250
Exelixis Inc -Detailed Product Pipeline
 February 2008 £250
Favrille Inc -Detailed Product Pipeline
 February 2008 £250
Eqitx Ltd -Detailed Product Pipeline
 February 2008 £250
Epigenomics AG -Detailed Product Pipeline
 February 2008 £250
Enzo Biochem Inc -Detailed Product Pipeline
 February 2008 £250
Enzon Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
EpiCept Corp -Detailed Product Pipeline
 February 2008 £250
Flamel Technologies SA ADS -Detailed Product Pipeline
 February 2008 £250
Forbes Medi -Tech Inc -Detailed Product Pipeline
 February 2008 £250
GW Pharmaceuticals PLC -Detailed Product Pipeline
 February 2008 £250
GammaCan International Inc -Detailed Product Pipeline
 February 2008 £250
Gedeon Richter Ltd -Detailed Product Pipeline
 February 2008 £250
GelStat Corp -Detailed Product Pipeline
 February 2008 £250
GTX INC -Detailed Product Pipeline
 February 2008 £250
GTC Biotherapeutics Inc -Detailed Product Pipeline
 February 2008 £250
Forest Laboratories Inc -Detailed Product Pipeline
 February 2008 £250
Forticell Bioscience, Inc. -Detailed Product Pipeline
 February 2008 £250
GPC Biotech AG -Detailed Product Pipeline
 February 2008 £250
Cortex Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Corcept Therapeutics Inc -Detailed Product Pipeline
 February 2008 £250
Bentley Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Bio -Bridge Science Inc -Detailed Product Pipeline
 February 2008 £250
BioCryst Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
BioDelivery Sciences International Inc -Detailed Product Pipeline
 February 2008 £250
Benitec Ltd -Detailed Product Pipeline
 February 2008 £250
Benda Pharmaceutical, Inc -Detailed Product Pipeline
 February 2008 £250
Baxter International Inc -Detailed Product Pipeline
 February 2008 £250
Bayer Ag -Detailed Product Pipeline
 February 2008 £250
Bayer Schering Pharma AG -Detailed Product Pipeline
 February 2008 £250
Beijing Med -Pharm Corp. -Detailed Product Pipeline
 February 2008 £250
BioForm Medical, Inc. -Detailed Product Pipeline
 February 2008 £250
BioMarin Pharmaceutical Inc -Detailed Product Pipeline
 February 2008 £250
Biocon Ltd -Detailed Product Pipeline
 February 2008 £250
Biodel Inc. -Detailed Product Pipeline
 February 2008 £250
Biogen Idec Inc -Detailed Product Pipeline
 February 2008 £250
Bioniche Life Sciences Inc -Detailed Product Pipeline
 February 2008 £250
BioTime Inc -Detailed Product Pipeline
 February 2008 £250
BioSphere Medical Inc -Detailed Product Pipeline
 February 2008 £250
BioMimetic Therapeutics Inc -Detailed Product Pipeline
 February 2008 £250
BioSante Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
BioSpecifics Technologies Corp -Detailed Product Pipeline
 February 2008 £250
Bavarian Nordic AS -Detailed Product Pipeline
 February 2008 £250
Basilea Pharmaceutica AG -Detailed Product Pipeline
 February 2008 £250
AVI BioPharma Inc -Detailed Product Pipeline
 February 2008 £250
AXM Pharma Inc -Detailed Product Pipeline
 February 2008 £250
Amicus Therapeutics, Inc. -Detailed Product Pipeline
 February 2008 £250
Anavex Life Sciences Corp. -Detailed Product Pipeline
 February 2008 £250
AVAX TECHNOLOGIES INCORPORATED -Detailed Product Pipeline
 February 2008 £250
AVANT Immunotherapeutics Inc -Detailed Product Pipeline
 February 2008 £250
World Health Energy, Inc. -Detailed Product Pipeline
 February 2008 £250
3SBio Inc. -Detailed Product Pipeline
 February 2008 £250
AVANIR Pharmaceuticals -Detailed Product Pipeline
 February 2008 £250
Arana Therapeutics Limited -Detailed Product Pipeline
 February 2008 £250
Ardea Biosciences, Inc. -Detailed Product Pipeline
 February 2008 £250
Avigen Inc -Detailed Product Pipeline
 February 2008 £250
Axcan Pharma Inc -Detailed Product Pipeline
 February 2008 £250
Barr Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Barrier Therapeutics Inc -Detailed Product Pipeline
 February 2008 £250
Avicena Group Inc -Detailed Product Pipeline
 February 2008 £250
Avantogen Oncology, Inc. -Detailed Product Pipeline
 February 2008 £250
AstraZeneca Plc -Detailed Product Pipeline
 February 2008 £250
Auxilium Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Avalon Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Bionovo Inc -Detailed Product Pipeline
 February 2008 £250
Biophage Pharma Inc -Detailed Product Pipeline
 February 2008 £250
Ceragenix Phamaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Cerus Corporation -Detailed Product Pipeline
 February 2008 £250
Chattem Inc -Detailed Product Pipeline
 February 2008 £250
Chelsea Therapeutics International Ltd -Detailed Product Pipeline
 February 2008 £250
Cephalon Inc -Detailed Product Pipeline
 February 2008 £250
Celsion Corp -Detailed Product Pipeline
 February 2008 £250
Cell Genesys Inc -Detailed Product Pipeline
 February 2008 £250
Cell Therapeutics Inc -Detailed Product Pipeline
 February 2008 £250
Cellegy Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Chemgenex Pharmaceuticals Ltd -Detailed Product Pipeline
 February 2008 £250
Chemokine Therapeutics Corp -Detailed Product Pipeline
 February 2008 £250
CollaGenex Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Columbia Laboratories Inc -Detailed Product Pipeline
 February 2008 £250
CombinatoRx Inc -Detailed Product Pipeline
 February 2008 £250
Compugen Ltd -Detailed Product Pipeline
 February 2008 £250
Cobalis Corp -Detailed Product Pipeline
 February 2008 £250
Clinuvel Pharmaceuticals Ltd -Detailed Product Pipeline
 February 2008 £250
Chugai Pharmaceutical Co Ltd -Detailed Product Pipeline
 February 2008 £250
Cleveland Biolabs Inc -Detailed Product Pipeline
 February 2008 £250
Clinical Data Inc -Detailed Product Pipeline
 February 2008 £250
Celgene Corporation -Detailed Product Pipeline
 February 2008 £250
CeNeS Pharmaceuticals Plc -Detailed Product Pipeline
 February 2008 £250
Bradley Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Brainstorm Cell Therapeutics Inc -Detailed Product Pipeline
 February 2008 £250
Bristol -Myers Squibb Company -Detailed Product Pipeline
 February 2008 £250
CEL -SCI Corporation -Detailed Product Pipeline
 February 2008 £250
Biovest International Inc. -Detailed Product Pipeline
 February 2008 £250
Biovail Corporation -Detailed Product Pipeline
 February 2008 £250
Biopure Corporation -Detailed Product Pipeline
 February 2008 £250
Biosyntech Inc -Detailed Product Pipeline
 February 2008 £250
Biotech Holdings Ltd -Detailed Product Pipeline
 February 2008 £250
CV Therapeutics Inc -Detailed Product Pipeline
 February 2008 £250
CYTOGEN Corporation -Detailed Product Pipeline
 February 2008 £250
Cardium Therapeutics Inc -Detailed Product Pipeline
 February 2008 £250
Carribbean American Health Resorts Inc -Detailed Product Pipeline
 February 2008 £250
Carrington Laboratories Inc -Detailed Product Pipeline
 February 2008 £250
Catalyst Pharmaceutical Partners Inc. -Detailed Product Pipeline
 February 2008 £250
Cardiome Pharma Corp -Detailed Product Pipeline
 February 2008 £250
CardioVascular BioTherapeutics Inc -Detailed Product Pipeline
 February 2008 £250
Cadence Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Callisto Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Caraco Pharmaceutical Laboratories Ltd -Detailed Product Pipeline
 February 2008 £250
Hologic Inc -Detailed Product Pipeline
 February 2008 £250
Halozyme Therapeutics Inc -Detailed Product Pipeline
 February 2008 £250
Novelos Therapeutics Inc -Detailed Product Pipeline
 February 2008 £250
Noven Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Novo -Nordisk A -Detailed Product Pipeline
 February 2008 £250
Novogen Ltd -Detailed Product Pipeline
 February 2008 £250
Novavax Inc -Detailed Product Pipeline
 February 2008 £250
Novartis AG -Detailed Product Pipeline
 February 2008 £250
Northwest Biotherapeutics Inc -Detailed Product Pipeline
 February 2008 £250
Novacea Inc -Detailed Product Pipeline
 February 2008 £250
Novadel Pharma Inc -Detailed Product Pipeline
 February 2008 £250
Novozymes A -Detailed Product Pipeline
 February 2008 £250
Nucryst Pharmaceuticals Corp -Detailed Product Pipeline
 February 2008 £250
OSI Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
OXIS International Inc -Detailed Product Pipeline
 February 2008 £250
OXiGENE INC -Detailed Product Pipeline
 February 2008 £250
Oculus Innovative Sciences Inc -Detailed Product Pipeline
 February 2008 £250
Nymox Pharmaceutical Corporation -Detailed Product Pipeline
 February 2008 £250
Nventa Biopharmaceuticals Corp -Detailed Product Pipeline
 February 2008 £250
Nutra Pharma Corp -Detailed Product Pipeline
 February 2008 £250
Nutrition 21 Inc -Detailed Product Pipeline
 February 2008 £250
Nuvelo Inc. -Detailed Product Pipeline
 February 2008 £250
Northfield Laboratories Inc -Detailed Product Pipeline
 February 2008 £250
North American Scientific Inc -Detailed Product Pipeline
 February 2008 £250
NatureWell Inc -Detailed Product Pipeline
 February 2008 £250
Hospira Inc -Detailed Product Pipeline
 February 2008 £250
NeoPharm Inc -Detailed Product Pipeline
 February 2008 £250
Neose Technologies Inc -Detailed Product Pipeline
 February 2008 £250
Nastech Pharmaceutical Co Inc -Detailed Product Pipeline
 February 2008 £250
NanoViricides, Inc. -Detailed Product Pipeline
 February 2008 £250
Myriad Genetics Inc -Detailed Product Pipeline
 February 2008 £250
NPS Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Nabi Biopharmaceuticals -Detailed Product Pipeline
 February 2008 £250
Neuro -Hitech Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Neurobiological Technologies Inc -Detailed Product Pipeline
 February 2008 £250
Neurologix Inc -Detailed Product Pipeline
 February 2008 £250
NexMed Inc -Detailed Product Pipeline
 February 2008 £250
Nile Therapeutics, Inc -Detailed Product Pipeline
 February 2008 £250
Nitromed Inc -Detailed Product Pipeline
 February 2008 £250
NeurogesX, Inc. -Detailed Product Pipeline
 February 2008 £250
Neurogenesis Inc -Detailed Product Pipeline
 February 2008 £250
Neurochem Inc -Detailed Product Pipeline
 February 2008 £250
Neurocrine Biosciences Inc -Detailed Product Pipeline
 February 2008 £250
Neurogen Corporation -Detailed Product Pipeline
 February 2008 £250
Omrix Biopharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
OncoVista, Inc. -Detailed Product Pipeline
 February 2008 £250
Pharmacyclics Inc -Detailed Product Pipeline
 February 2008 £250
Pharmasset, Inc. -Detailed Product Pipeline
 February 2008 £250
Pharmaxis Ltd. -Detailed Product Pipeline
 February 2008 £250
Pharming Group N.V. -Detailed Product Pipeline
 February 2008 £250
Pharmacopeia, Inc. -Detailed Product Pipeline
 February 2008 £250
Pfizer Inc -Detailed Product Pipeline
 February 2008 £250
Peplin Ltd -Detailed Product Pipeline
 February 2008 £250
Peregrine Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Perrigo Company -Detailed Product Pipeline
 February 2008 £250
Pharmion Corp -Detailed Product Pipeline
 February 2008 £250
Pharmos Corporation -Detailed Product Pipeline
 February 2008 £250
Point Therapeutics Inc -Detailed Product Pipeline
 February 2008 £250
Polydex Pharmaceuticals Ltd -Detailed Product Pipeline
 February 2008 £250
Poniard Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Prana Biotechnology Ltd -Detailed Product Pipeline
 February 2008 £250
Pluristem Therapeutics, Inc. -Detailed Product Pipeline
 February 2008 £250
Pipex Pharmaceuticals, Inc. -Detailed Product Pipeline
 February 2008 £250
Phosphagenics Ltd. -Detailed Product Pipeline
 February 2008 £250
Phytopharm PLC -Detailed Product Pipeline
 February 2008 £250
Pilot Therapeutics Holdings Inc -Detailed Product Pipeline
 February 2008 £250
Penwest Pharmaceuticals Co -Detailed Product Pipeline
 February 2008 £250
Par Pharmaceutical Companies Inc -Detailed Product Pipeline
 February 2008 £250
Optimer Pharmaceuticals, Inc. -Detailed Product Pipeline
 February 2008 £250
Oragenics Inc -Detailed Product Pipeline
 February 2008 £250
Oramed Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Orchid Chemicals & Pharmaceuticals Ltd -Detailed Product Pipeline
 February 2008 £250
Opko Health, Inc. -Detailed Product Pipeline
 February 2008 £250
Opexa Therapeutics Inc -Detailed Product Pipeline
 February 2008 £250
Oncolytics Biotech Inc -Detailed Product Pipeline
 February 2008 £250
Oncothyreon, Inc. -Detailed Product Pipeline
 February 2008 £250
Onyx Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
OrthoLogic Corporation -Detailed Product Pipeline
 February 2008 £250
Orthovita Inc -Detailed Product Pipeline
 February 2008 £250
PacificHealth Laboratories Inc -Detailed Product Pipeline
 February 2008 £250
Pain Therapeutics Inc -Detailed Product Pipeline
 February 2008 £250
Palatin Technologies Inc -Detailed Product Pipeline
 February 2008 £250
Panacos Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
POZEN Inc -Detailed Product Pipeline
 February 2008 £250
PDL BioPharma Inc -Detailed Product Pipeline
 February 2008 £250
Oscient Pharmaceuticals Corp -Detailed Product Pipeline
 February 2008 £250
Osiris Therapeutics Inc -Detailed Product Pipeline
 February 2008 £250
Osteologix, Inc. -Detailed Product Pipeline
 February 2008 £250
Mymetics Corporation -Detailed Product Pipeline
 February 2008 £250
Nektar Therapeutics -Detailed Product Pipeline
 February 2008 £250
InterMune Inc -Detailed Product Pipeline
 February 2008 £250
Interpharm Holdings Inc -Detailed Product Pipeline
 February 2008 £250
Introgen Therapeutics Inc -Detailed Product Pipeline
 February 2008 £250
Inyx Inc -Detailed Product Pipeline
 February 2008 £250
Intellect Neurosciences, Inc. -Detailed Product Pipeline
 February 2008 £250
IntelGenx Technologies Corp. -Detailed Product Pipeline
 February 2008 £250
Inovio Biomedical Corp -Detailed Product Pipeline
 February 2008 £250
Insmed Incorporated -Detailed Product Pipeline
 February 2008 £250
Inspire Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Iomai Corp -Detailed Product Pipeline
 February 2008 £250
Isis Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Keryx Biopharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
King Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Kosan Biosciences Incorporated -Detailed Product Pipeline
 February 2008 £250
Kyto BioPharma Inc -Detailed Product Pipeline
 February 2008 £250
KV Pharmaceutical Co. -Detailed Product Pipeline
 February 2008 £250
Johnson & Johnson -Detailed Product Pipeline
 February 2008 £250
IsoRay Inc -Detailed Product Pipeline
 February 2008 £250
Javelin Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Mylan, Inc. -Detailed Product Pipeline
 February 2008 £250
Innovive Pharmaceuticals, Inc. -Detailed Product Pipeline
 February 2008 £250
Inhibitex Inc -Detailed Product Pipeline
 February 2008 £250
Idenix Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Idera Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Imagenetix Inc -Detailed Product Pipeline
 February 2008 £250
Imarx Therapeutics, Inc. -Detailed Product Pipeline
 February 2008 £250
ISTA Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
IMCOR Pharmaceutical Co. -Detailed Product Pipeline
 February 2008 £250
Human Genome Sciences Inc -Detailed Product Pipeline
 February 2008 £250
ICAgen Inc -Detailed Product Pipeline
 February 2008 £250
IDM Pharma Inc -Detailed Product Pipeline
 February 2008 £250
Imclone Systems Inc -Detailed Product Pipeline
 February 2008 £250
Immtech Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Incyte Corporation -Detailed Product Pipeline
 February 2008 £250
Indevus Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Infinity Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Inflazyme Pharmaceuticals Ltd. -Detailed Product Pipeline
 February 2008 £250
InSite Vision Incorporated -Detailed Product Pipeline
 February 2008 £250
InNexus Biotechnology Inc -Detailed Product Pipeline
 February 2008 £250
ImmunoGen Inc -Detailed Product Pipeline
 February 2008 £250
Immunomedics Inc -Detailed Product Pipeline
 February 2008 £250
Impax Laboratories Inc -Detailed Product Pipeline
 February 2008 £250
LAM Pharmaceutical Corp -Detailed Product Pipeline
 February 2008 £250
Jazz Pharmaceuticals, Inc. -Detailed Product Pipeline
 February 2008 £250
La Jolla Pharmaceutical Co -Detailed Product Pipeline
 February 2008 £250
Metabasis Therapeutics Inc -Detailed Product Pipeline
 February 2008 £250
Metabolic Pharmaceuticals Ltd. -Detailed Product Pipeline
 February 2008 £250
MethylGene Inc -Detailed Product Pipeline
 February 2008 £250
Mentor Corporation -Detailed Product Pipeline
 February 2008 £250
Memory Pharmaceuticals Corp -Detailed Product Pipeline
 February 2008 £250
Medicis Pharmaceutical Corp -Detailed Product Pipeline
 February 2008 £250
Medicure Inc -Detailed Product Pipeline
 February 2008 £250
Medivation Inc -Detailed Product Pipeline
 February 2008 £250
Meldex International Plc -Detailed Product Pipeline
 February 2008 £250
MicroIslet, Inc. -Detailed Product Pipeline
 February 2008 £250
Micromet Inc -Detailed Product Pipeline
 February 2008 £250
Modigene, Inc. -Detailed Product Pipeline
 February 2008 £250
Molecular Insight Pharmaceuticals, Inc. -Detailed Product Pipeline
 February 2008 £250
Momenta Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
MultiCell Technologies Inc -Detailed Product Pipeline
 February 2008 £250
Miravant Medical Technologies -Detailed Product Pipeline
 February 2008 £250
Minrad International Inc -Detailed Product Pipeline
 February 2008 £250
MiddleBrook Pharmaceuticals, Inc. -Detailed Product Pipeline
 February 2008 £250
Migenix Inc -Detailed Product Pipeline
 February 2008 £250
Millennium Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
MediciNova Inc -Detailed Product Pipeline
 February 2008 £250
Merck & Co Inc -Detailed Product Pipeline
 February 2008 £250
Lexicon Pharmaceuticals, Inc -Detailed Product Pipeline
 February 2008 £250
Ligand Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Lorus Therapeutics Inc -Detailed Product Pipeline
 February 2008 £250
Lotus Pharmaceuticals, Inc. -Detailed Product Pipeline
 February 2008 £250
Lev Pharmaceuticals Inc -Detailed Product Pipeline
 February 2008 £250
Lescarden Inc -Detailed Product Pipeline
 February 2008 £250
Labopharm Inc -Detailed Product Pipeline
 February 2008 £250
Lannett Co Inc -Detailed Product Pipeline
 February 2008 £250
Medarex Inc -Detailed Product Pipeline
 February 2008 £250
Lpath Inc -Detailed Product Pipeline
 February 2008 £250
Lee Pharmaceuticals -Detailed Product Pipeline
 February 2008 £250
Matrixx Initiatives Inc -Detailed Product Pipeline
 February 2008 £250
Maxygen Inc -Detailed Product Pipeline
 February 2008 £250
Med Gen Inc -Detailed Product Pipeline
 February 2008 £250
Mannatech Inc -Detailed Product Pipeline
 February 2008 £250
Marshall Edwards Inc -Detailed Product Pipeline
 February 2008 £250
MGI Pharma Inc -Detailed Product Pipeline
 February 2008 £250
MannKind Corp -Detailed Product Pipeline
 February 2008 £250
MacroChem Corporation -Detailed Product Pipeline
 February 2008 £250
Manhattan Pharmaceuticals Inc. -Detailed Product Pipeline
 February 2008 £250
Commercial and Pipeline Insight: Hepatitis B
 October 2007 £5020
Commercial & Pipeline Insight: Hospital Antibacterials A market beyond MRSA
 August 2007 £5290
Commercial Insight: Antidiabetics Patent expiries and cost containment initiatives balanced by pipeline products
 August 2007 £5290
Pipeline Insight: Heart failure Week pipeline dominated by new indications and add-on diuretics
 August 2007 £3965
Pipeline And Commercial Insight
Pediatric And Adolescent Vaccines
 July 2007 £5285
Indication Expansion
Opportunities for successful lifecycle management
 March 2007 £1495
Next Generation Protein Engineering and Drug Design
Strategies to boost efficacy and improve drug delivery
 February 2007 £1495
New Drug Futures: Cancer Chapter
 May 2006 £695
New Drug Futures: Anti-Infective Chapter
 May 2006 £695
New Drug Futures
 May 2006 £2995
New Drug Futures: Cardiovascular Chapter
 May 2006 £695
New Drug Futures: Alimentary/Metabolic Chapter
 May 2006 £695
New Drug Futures: Musculoskeletal Chapter
 May 2006 £695
New Drug Futures: Respiratory Chapter
 May 2006 £695
New Drug Futures: Central Nervous System Chapter
 May 2006 £695
New Drug Futures: Vaccines Chapter
 May 2006 £695
The Impact of the Phase III Pipeline
Future Projections and Market Disruptions
 March 2006 £2310